Timothy J Lorber - 13 Jun 2024 Form 3 Insider Report for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Role: Chief Financial Officer
Signature: /s/ Timothy J. Lorber
Issuer symbol: SHPH
Transactions as of: 13 Jun 2024
Net transactions value: $0
Form type: 3
Filing time: 25 Jun 2024, 17:42:34 UTC
Next filing: 12 Aug 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SHPH	COMMON STOCK						227,635	13 Jun 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The undersigned became a Reporting Person subject to Section 16 reporting effective June 13, 2024 when he started serving as the Company's Chief Financial Officer. Reporting Person is the beneficial owner of 227,635 restricted stock units ("RSUs") issued under the Company's 2018 Equity Incentive Plan, which RSUs vest annually in one third increments on June 13, 2025, June 13, 2026 and June 13, 2027.

Content

The undersigned became a Reporting Person subject to Section 16 reporting effective June 13, 2024 when he started serving as the Company's Chief Financial Officer. Reporting Person is the beneficial owner of 227,635 restricted stock units ("RSUs") issued under the Company's 2018 Equity Incentive Plan, which RSUs vest annually in one third increments on June 13, 2025, June 13, 2026 and June 13, 2027.